🇺🇸 FDA
Patent

US 9409880

Modulators of TLR3/dsRNA complex and uses thereof

granted A61KA61K31/381A61K31/404

Quick answer

US patent 9409880 (Modulators of TLR3/dsRNA complex and uses thereof) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/381, A61K31/404, A61P, A61P31/00